Expression of MDM2, MDM4 and p53 and Association with Outcome in 162 Cases of Gastric Adenocarcinoma

被引：0
|
作者：
Rock, J. B. [1 ]
Hatzaras, I. S. [1 ]
Suarez, A. A. [1 ]
Zhou, X. [1 ]
Bloomston, M. P. [1 ]
Frankel, W. L. [1 ]
机构：
[1] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
694
引用
下载
收藏
页码：166A / 166A
页数：1
相关论文
共 50 条
  • [1] Expression of MDM2, MDM4 and p53 and Association with Outcome in 162 Cases of Gastric Adenocarcinoma.
    Rock, J. B.
    Hatzaras, I. S.
    Suarez, A. A.
    Zhou, X.
    Bloomston, M. P.
    Frankel, W. L.
    LABORATORY INVESTIGATION, 2011, 91 : 166A - 166A
  • [2] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
  • [3] Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4
    Fan, Chuandong
    Wang, Xinjiang
    CELL CYCLE, 2017, 16 (07) : 660 - 664
  • [4] Selective and dual action p53/mdm2/mdm4 antagonists
    Wang, Kan
    Doemling, Alexander
    CANCER RESEARCH, 2009, 69
  • [5] MDM2 and MDM4: p53 regulators as targets in anticancer therapy
    Toledo, Franck
    Wahl, Geoffrey M.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8): : 1476 - 1482
  • [6] Mdm2 and Mdm4 loss regulates distinct p53 activities
    Barboza, Juan A.
    Iwakuma, Tomoo
    Terzian, Tamara
    El-Naggar, Adel K.
    Lozano, Guillermina
    MOLECULAR CANCER RESEARCH, 2008, 6 (06) : 947 - 954
  • [7] Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
    Pant, Vinod
    Xiong, Shunbin
    Iwakuma, Tomoo
    Quintas-Cardama, Alfonso
    Lozano, Guillermina
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 11995 - 12000
  • [8] Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder Cancer
    Kriegmair, Maximilian Christian
    Balk, Matthias
    Wirtz, Ralph
    Steidler, Annette
    Weis, Cleo-Aron
    Breyer, Johannes
    Hartmann, Arndt
    Bolenz, Christian
    Erben, Philipp
    ANTICANCER RESEARCH, 2016, 36 (10) : 5205 - 5213
  • [9] Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review
    Teveroni, Emanuela
    Luca, Rossella
    Pellegrino, Marsha
    Ciolli, Germana
    Pontecorvi, Alfredo
    Moretti, Fabiola
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (12) : 1417 - 1429
  • [10] Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4
    Grier, JD
    Xiong, SB
    Elizondo-Fraire, AC
    Parant, JM
    Lozano, G
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (01) : 192 - 198
12345